A critical advance in cancer research is occurring with the use of VHH fragments to reactivate mutated p53. This essential cancer protector protein is frequently disabled in many forms of cancer, resulting uncontrolled https://johsocial.com/story12666735/vhh-fragments-reactivate-tumor-suppressor-p53-the-potential-hope-for-tumor-management